SecBot SecBot
8-K ·Filed May 5, 2026

FTRE

Fortrea Holdings Inc.
MIXED
Impact 5/10
Horizonweeks Processed5mo ago SEC0001628280-26-030101
8-K Item 2.02: Earnings release
Actionable Insight ◆ Mixed

The strong adjusted EPS beat and third consecutive quarter of book-to-bill above 1.1x suggest operational momentum, but the YoY revenue decline and negative free cash flow warrant caution. Monitor the Q2 2026 earnings for signs of revenue stabilization and progress toward positive free cash flow.

DirectionMixed
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
FTRE ▲ +31.31% at T+60d
NEUTRAL call +31.31% · α vs SPY +28.57% · entry $14.53 → $19.08
Entry = T+0 close
May 5, 2026
via day close
T+1d
+7.64%
call +7.64% · α +6.25%
$15.64
settled 6mo ago
T+5d
+0.55%
call +0.55% · α -1.43%
$14.61
settled 6mo ago
T+20d
+5.71%
call +5.71% · α +0.76%
$15.36
settled 5mo ago
T+60d
+31.31%
call +31.31% · α +28.57%
$19.08
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Fortrea reported Q1 2026 revenue of $636.5M (down 2.3% YoY from $651.3M) and an adjusted diluted EPS of $0.16, significantly above the $0.03 Street consensus. The company affirmed its FY2026 guidance of $2.55B-$2.65B revenue and $190M-$220M adjusted EBITDA. While the adjusted EPS beat is notable, the ongoing revenue decline and negative free cash flow of -$25.0M temper the outlook.

Key Financial Metrics

EPS
$0.16
est $0.03 · +433.3%
Revenue
$636.5M
est $625.9M · +1.7% · -2.3% YoY
Rating
beat
Guidance
$2.55B-$2.65B
maintained
Free Cash Flow
-$25.0M

Key Facts

  • Q1 2026 revenue of $636.5M, down 2.3% YoY from $651.3M
  • GAAP net loss of $23.6M ($0.25 loss per diluted share)
  • Adjusted diluted EPS of $0.16 vs Street consensus of $0.03 (433% beat)
  • Adjusted EBITDA of $47.0M, up 55% YoY from $30.3M
  • Book-to-bill ratio of 1.15x, third consecutive quarter above 1.1x
  • Backlog of $7,846M as of March 31, 2026
  • FY2026 guidance affirmed: revenue $2.55B-$2.65B, adjusted EBITDA $190M-$220M
  • Free cash flow of -$25.0M in Q1 2026

Financial Impact

Adjusted EPS of $0.16 beat consensus of $0.03 by $0.13, a 433% surprise. Revenue of $636.5M was above the $625.9M consensus estimate by 1.7%.

revenueepscashFlow

Risk Factors

  • Continued YoY revenue decline of 2.3% signals ongoing top-line pressure
  • Negative free cash flow of -$25.0M raises liquidity concerns
  • High debt load of $1.05B long-term debt vs $147.5M cash
  • Guidance affirmed but unchanged, leaving no upside catalyst

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
59% bullish (17 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001628280-26-030101
Document: ftre-20260505.htm0001628280-26-030101
Document: 0001628280-26-030101-index-headers.html0001628280-26-030101
Document: 0001628280-26-030101-index.html0001628280-26-030101
Document: 0001628280-26-030101.txt0001628280-26-030101
8-K Data (Synthetic)0001628280-26-030101
22 reports for FTRE
Performance horizon
100% Hit rate @ T+1 3 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +11.57%Feb 26, 2026
Filters
Rows
Reports for FTRE — sortable, filterable
TypeNow
Oct 27, 2026
today
Press Release
NEUTRAL ★ 2/10
$23.63awaiting T+1—$24.23 (+2.52%)
Oct 22, 2026
4d ago
Press Release
NEUTRAL ★ 3/10
$23.63 $23.83▲ +0.85%▲ +0.14%$24.23 (+2.52%)
Oct 19, 2026
7d ago
Press Release
BULLISH ★ 5/10
$22.78 $24.06▲ +5.62%▲ +5.09%$24.23 (+6.34%)
Oct 5, 2026
22d ago
Press Release
NEUTRAL ★ 1/10
$21.11 $20.78▼ −1.56%▼ −2.11%$24.23 (+14.76%)
Sep 30, 2026
26d ago
8-K
NEUTRAL ★ 2/10
$19.40 $20.00▲ +3.09%▲ +2.35%$24.23 (+24.87%)
Sep 10, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$17.20 $17.41▲ +1.22%▲ +1.67%$24.23 (+40.84%)
Sep 10, 2026
6w ago
8-K
NEUTRAL ★ 3/10
$17.02 $17.20▲ +1.06%▲ +0.21%$24.23 (+42.33%)
Sep 2, 2026
7w ago
Press Release
BULLISH ★ 6/10
$18.36 $18.62▲ +1.42%▲ +0.37%$24.23 (+31.94%)
Aug 22, 2026
9w ago
Institutional Cluster
MIXED ★ 5/10
$18.31 $18.27▼ −0.22%▼ −0.54%$24.23 (+32.30%)
Aug 7, 2026
11w ago
Insider Cluster
MIXED ★ 5/10
$18.99 $19.52▲ +2.79%▲ +3.11%$24.23 (+27.57%)
Showing 10 of 22

US Market Status

Market Open — Closes in 3h 31m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 5, 2026